Fig. 1 · Structure

Documents & Downloads

Cenicriviroc

Cat. No. A13643 CAS 497223-25-3

CCR2/CCR5 inhibitor

Cenicriviroc is an experimental drug candidate for the treatment of HIV infection.Cenicriviroc is an inhibitor of CCR2 and CCR5 receptors, allowing it to function as an entry inhibitor which prevents the virus from entering into a human cell.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
CCR5 IC50 0.29 nM
CCR2 IC50 5.9 nM
R5 HIV-1 0.024-0.08 nM (IC50, in PBMCs)
R5 HIV-2 0.03-0.98 nM (IC50, in PBMCs)

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 497223-25-3
Applications CCR2/CCR5 inhibitor
Formula C41H52N4O4S
Molecular Weight 696.94
Synonyms TAK-652; TBR-652
SMILES
CCCCOCCOC1=CC=C(C=C1)C2=CC/3=C(C=C2)N(CCC/C(=C3)/C(=O)NC4=CC=C(C=C4)[S@@](=O)CC5=CN=CN5CCC)CC(C)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 94 mg/mL (134.87 mM)
Water Insoluble
Ethanol 94 mg/mL (134.87 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...